ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pre-Exposure Prophylaxis (PrEP) Market Research Report 2026
Published Date: 2026-02-10
|
Report Code: QYRE-Auto-29X18132
Home | Market Reports | Health| Pharmacy
Global Pre Exposure Prophylaxis PrEP Market Research Report 2024
BUY CHAPTERS

Global Pre-Exposure Prophylaxis (PrEP) Market Research Report 2026

Code: QYRE-Auto-29X18132
Report
2026-02-10
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Gilead Sciences
ViiV Healthcare
TEVA
Amneal Pharmaceuticals
Aurobindo Pharma
Mylan NV
Zydus
Qilu Pharmaceutical
Chengdu Brilliant Pharmaceutical
North China Pharmaceutical
Chia Tai-Tianqing Pharmaceutical
Anhui Baker Biopharmaceutical

Pre-Exposure Prophylaxis (PrEP) Market

The global Pre-Exposure Prophylaxis (PrEP) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pre-Exposure Prophylaxis (PrEP) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Pre-Exposure Prophylaxis (PrEP) is a preventive medical strategy for individuals at high risk of contracting HIV, involving the use of antiretroviral medication to significantly reduce the likelihood of infection. When taken consistently, PrEP can lower the risk of HIV transmission by up to 99% in high-risk populations, such as men who have sex with men and heterosexual couples with an HIV-positive partner. PrEP typically includes medications like tenofovir disoproxil fumarate and emtricitabine, taken orally on a daily basis or as directed by a healthcare provider.
The North American market for Pre-Exposure Prophylaxis (PrEP) is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Pre-Exposure Prophylaxis (PrEP) is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Pre-Exposure Prophylaxis (PrEP) include Gilead Sciences, ViiV Healthcare, Teva, Amneal Pharmaceuticals, Aurobindo Pharma, Mylan, Zydus, Qilu Pharmaceutical, Anhui Baker Biopharmaceutical, Chengdu Brilliant Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Pre-Exposure Prophylaxis (PrEP) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pre-Exposure Prophylaxis (PrEP). The Pre-Exposure Prophylaxis (PrEP) market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pre-Exposure Prophylaxis (PrEP) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pre-Exposure Prophylaxis (PrEP) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Pre-Exposure Prophylaxis (PrEP) Market Report

Report Metric Details
Report Name Pre-Exposure Prophylaxis (PrEP) Market
Segment by Type
  • Oral PrEP
  • Injectable PrEP
by Application
  • Hospital and Clinic
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Gilead Sciences, ViiV Healthcare, Teva, Amneal Pharmaceuticals, Aurobindo Pharma, Mylan, Zydus, Qilu Pharmaceutical, Anhui Baker Biopharmaceutical, Chengdu Brilliant Pharmaceutical, North China Pharmaceutical, Chia Tai Tianqing Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Pre-Exposure Prophylaxis (PrEP) manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Pre-Exposure Prophylaxis (PrEP) sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Pre-Exposure Prophylaxis (PrEP) Market report?

Ans: The main players in the Pre-Exposure Prophylaxis (PrEP) Market are Gilead Sciences, ViiV Healthcare, Teva, Amneal Pharmaceuticals, Aurobindo Pharma, Mylan, Zydus, Qilu Pharmaceutical, Anhui Baker Biopharmaceutical, Chengdu Brilliant Pharmaceutical, North China Pharmaceutical, Chia Tai Tianqing Pharmaceutical

What are the Application segmentation covered in the Pre-Exposure Prophylaxis (PrEP) Market report?

Ans: The Applications covered in the Pre-Exposure Prophylaxis (PrEP) Market report are Hospital and Clinic, Pharmacy, Other

What are the Type segmentation covered in the Pre-Exposure Prophylaxis (PrEP) Market report?

Ans: The Types covered in the Pre-Exposure Prophylaxis (PrEP) Market report are Oral PrEP, Injectable PrEP

1 Pre-Exposure Prophylaxis (PrEP) Market Overview
1.1 Product Definition
1.2 Pre-Exposure Prophylaxis (PrEP) by Type
1.2.1 Global Pre-Exposure Prophylaxis (PrEP) Market Value by Type: 2025 vs 2032
1.2.2 Oral PrEP
1.2.3 Injectable PrEP
1.3 Pre-Exposure Prophylaxis (PrEP) by Application
1.3.1 Global Pre-Exposure Prophylaxis (PrEP) Market Value by Application: 2025 vs 2032
1.3.2 Hospital and Clinic
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Pre-Exposure Prophylaxis (PrEP) Market Size Estimates and Forecasts
1.4.1 Global Pre-Exposure Prophylaxis (PrEP) Revenue 2021–2032
1.4.2 Global Pre-Exposure Prophylaxis (PrEP) Sales 2021–2032
1.4.3 Global Pre-Exposure Prophylaxis (PrEP) Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Pre-Exposure Prophylaxis (PrEP) Market Competition by Manufacturers
2.1 Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Manufacturers (2021–2026)
2.2 Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Pre-Exposure Prophylaxis (PrEP) Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Pre-Exposure Prophylaxis (PrEP), Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Pre-Exposure Prophylaxis (PrEP), Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Pre-Exposure Prophylaxis (PrEP), Product Types and Applications
2.7 Global Key Manufacturers of Pre-Exposure Prophylaxis (PrEP), Date of Entry into the Industry
2.8 Global Pre-Exposure Prophylaxis (PrEP) Market Competitive Situation and Trends
2.8.1 Global Pre-Exposure Prophylaxis (PrEP) Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Pre-Exposure Prophylaxis (PrEP) Players Market Share by Revenue
2.8.3 Global Pre-Exposure Prophylaxis (PrEP) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pre-Exposure Prophylaxis (PrEP) Market Scenario by Region
3.1 Global Pre-Exposure Prophylaxis (PrEP) Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Pre-Exposure Prophylaxis (PrEP) Sales by Region: 2021–2032
3.2.1 Global Pre-Exposure Prophylaxis (PrEP) Sales by Region: 2021–2026
3.2.2 Global Pre-Exposure Prophylaxis (PrEP) Sales by Region: 2027–2032
3.3 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Region: 2021–2032
3.3.1 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Region: 2021–2026
3.3.2 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Region: 2027–2032
3.4 North America Pre-Exposure Prophylaxis (PrEP) Market Facts & Figures by Country
3.4.1 North America Pre-Exposure Prophylaxis (PrEP) Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Pre-Exposure Prophylaxis (PrEP) Sales by Country (2021–2032)
3.4.3 North America Pre-Exposure Prophylaxis (PrEP) Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pre-Exposure Prophylaxis (PrEP) Market Facts & Figures by Country
3.5.1 Europe Pre-Exposure Prophylaxis (PrEP) Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Pre-Exposure Prophylaxis (PrEP) Sales by Country (2021–2032)
3.5.3 Europe Pre-Exposure Prophylaxis (PrEP) Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pre-Exposure Prophylaxis (PrEP) Market Facts & Figures by Region
3.6.1 Asia Pacific Pre-Exposure Prophylaxis (PrEP) Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Pre-Exposure Prophylaxis (PrEP) Sales by Region (2021–2032)
3.6.3 Asia Pacific Pre-Exposure Prophylaxis (PrEP) Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pre-Exposure Prophylaxis (PrEP) Market Facts & Figures by Country
3.7.1 Latin America Pre-Exposure Prophylaxis (PrEP) Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Pre-Exposure Prophylaxis (PrEP) Sales by Country (2021–2032)
3.7.3 Latin America Pre-Exposure Prophylaxis (PrEP) Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pre-Exposure Prophylaxis (PrEP) Market Facts & Figures by Country
3.8.1 Middle East and Africa Pre-Exposure Prophylaxis (PrEP) Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Pre-Exposure Prophylaxis (PrEP) Sales by Country (2021–2032)
3.8.3 Middle East and Africa Pre-Exposure Prophylaxis (PrEP) Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pre-Exposure Prophylaxis (PrEP) Sales by Type (2021–2032)
4.1.1 Global Pre-Exposure Prophylaxis (PrEP) Sales by Type (2021–2026)
4.1.2 Global Pre-Exposure Prophylaxis (PrEP) Sales by Type (2027–2032)
4.1.3 Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Type (2021–2032)
4.2 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2021–2032)
4.2.1 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2021–2026)
4.2.2 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2027–2032)
4.2.3 Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Type (2021–2032)
4.3 Global Pre-Exposure Prophylaxis (PrEP) Price by Type (2021–2032)
5 Segment by Application
5.1 Global Pre-Exposure Prophylaxis (PrEP) Sales by Application (2021–2032)
5.1.1 Global Pre-Exposure Prophylaxis (PrEP) Sales by Application (2021–2026)
5.1.2 Global Pre-Exposure Prophylaxis (PrEP) Sales by Application (2027–2032)
5.1.3 Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Application (2021–2032)
5.2 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2021–2032)
5.2.1 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2021–2026)
5.2.2 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2027–2032)
5.2.3 Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Application (2021–2032)
5.3 Global Pre-Exposure Prophylaxis (PrEP) Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Gilead Sciences
6.1.1 Gilead Sciences Company Information
6.1.2 Gilead Sciences Description and Business Overview
6.1.3 Gilead Sciences Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Gilead Sciences Pre-Exposure Prophylaxis (PrEP) Product Portfolio
6.1.5 Gilead Sciences Recent Developments/Updates
6.2 ViiV Healthcare
6.2.1 ViiV Healthcare Company Information
6.2.2 ViiV Healthcare Description and Business Overview
6.2.3 ViiV Healthcare Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 ViiV Healthcare Pre-Exposure Prophylaxis (PrEP) Product Portfolio
6.2.5 ViiV Healthcare Recent Developments/Updates
6.3 Teva
6.3.1 Teva Company Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Teva Pre-Exposure Prophylaxis (PrEP) Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Amneal Pharmaceuticals
6.4.1 Amneal Pharmaceuticals Company Information
6.4.2 Amneal Pharmaceuticals Description and Business Overview
6.4.3 Amneal Pharmaceuticals Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Amneal Pharmaceuticals Pre-Exposure Prophylaxis (PrEP) Product Portfolio
6.4.5 Amneal Pharmaceuticals Recent Developments/Updates
6.5 Aurobindo Pharma
6.5.1 Aurobindo Pharma Company Information
6.5.2 Aurobindo Pharma Description and Business Overview
6.5.3 Aurobindo Pharma Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Aurobindo Pharma Pre-Exposure Prophylaxis (PrEP) Product Portfolio
6.5.5 Aurobindo Pharma Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Company Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Mylan Pre-Exposure Prophylaxis (PrEP) Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 Zydus
6.7.1 Zydus Company Information
6.7.2 Zydus Description and Business Overview
6.7.3 Zydus Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Zydus Pre-Exposure Prophylaxis (PrEP) Product Portfolio
6.7.5 Zydus Recent Developments/Updates
6.8 Qilu Pharmaceutical
6.8.1 Qilu Pharmaceutical Company Information
6.8.2 Qilu Pharmaceutical Description and Business Overview
6.8.3 Qilu Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Qilu Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Product Portfolio
6.8.5 Qilu Pharmaceutical Recent Developments/Updates
6.9 Anhui Baker Biopharmaceutical
6.9.1 Anhui Baker Biopharmaceutical Company Information
6.9.2 Anhui Baker Biopharmaceutical Description and Business Overview
6.9.3 Anhui Baker Biopharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Anhui Baker Biopharmaceutical Pre-Exposure Prophylaxis (PrEP) Product Portfolio
6.9.5 Anhui Baker Biopharmaceutical Recent Developments/Updates
6.10 Chengdu Brilliant Pharmaceutical
6.10.1 Chengdu Brilliant Pharmaceutical Company Information
6.10.2 Chengdu Brilliant Pharmaceutical Description and Business Overview
6.10.3 Chengdu Brilliant Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Chengdu Brilliant Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Product Portfolio
6.10.5 Chengdu Brilliant Pharmaceutical Recent Developments/Updates
6.11 North China Pharmaceutical
6.11.1 North China Pharmaceutical Company Information
6.11.2 North China Pharmaceutical Description and Business Overview
6.11.3 North China Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 North China Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Product Portfolio
6.11.5 North China Pharmaceutical Recent Developments/Updates
6.12 Chia Tai Tianqing Pharmaceutical
6.12.1 Chia Tai Tianqing Pharmaceutical Company Information
6.12.2 Chia Tai Tianqing Pharmaceutical Description and Business Overview
6.12.3 Chia Tai Tianqing Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Chia Tai Tianqing Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Product Portfolio
6.12.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pre-Exposure Prophylaxis (PrEP) Industry Chain Analysis
7.2 Pre-Exposure Prophylaxis (PrEP) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pre-Exposure Prophylaxis (PrEP) Production Mode & Process Analysis
7.4 Pre-Exposure Prophylaxis (PrEP) Sales and Marketing
7.4.1 Pre-Exposure Prophylaxis (PrEP) Sales Channels
7.4.2 Pre-Exposure Prophylaxis (PrEP) Distributors
7.5 Pre-Exposure Prophylaxis (PrEP) Customer Analysis
8 Pre-Exposure Prophylaxis (PrEP) Market Dynamics
8.1 Pre-Exposure Prophylaxis (PrEP) Industry Trends
8.2 Pre-Exposure Prophylaxis (PrEP) Market Drivers
8.3 Pre-Exposure Prophylaxis (PrEP) Market Challenges
8.4 Pre-Exposure Prophylaxis (PrEP) Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Gilead Sciences
ViiV Healthcare
TEVA
Amneal Pharmaceuticals
Aurobindo Pharma
Mylan NV
Zydus
Qilu Pharmaceutical
Chengdu Brilliant Pharmaceutical
North China Pharmaceutical
Chia Tai-Tianqing Pharmaceutical
Anhui Baker Biopharmaceutical
List of Tables
 Table 1. Global Pre-Exposure Prophylaxis (PrEP) Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Pre-Exposure Prophylaxis (PrEP) Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Pre-Exposure Prophylaxis (PrEP) Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Pre-Exposure Prophylaxis (PrEP) Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Pre-Exposure Prophylaxis (PrEP) Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Pre-Exposure Prophylaxis (PrEP) Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Pre-Exposure Prophylaxis (PrEP) Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Pre-Exposure Prophylaxis (PrEP), Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Pre-Exposure Prophylaxis (PrEP), Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Pre-Exposure Prophylaxis (PrEP), Product Types and Applications
 Table 12. Global Key Manufacturers of Pre-Exposure Prophylaxis (PrEP), Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pre-Exposure Prophylaxis (PrEP) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pre-Exposure Prophylaxis (PrEP) Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pre-Exposure Prophylaxis (PrEP) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Pre-Exposure Prophylaxis (PrEP) Sales by Region (K Units), 2021–2026
 Table 18. Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Region (2021–2026)
 Table 19. Global Pre-Exposure Prophylaxis (PrEP) Sales by Region (K Units), 2027–2032
 Table 20. Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Region (2027–2032)
 Table 21. Global Pre-Exposure Prophylaxis (PrEP) Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Region (2021–2026)
 Table 23. Global Pre-Exposure Prophylaxis (PrEP) Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Region (2027–2032)
 Table 25. North America Pre-Exposure Prophylaxis (PrEP) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Pre-Exposure Prophylaxis (PrEP) Sales by Country (K Units), 2021–2026
 Table 27. North America Pre-Exposure Prophylaxis (PrEP) Sales by Country (K Units), 2027–2032
 Table 28. North America Pre-Exposure Prophylaxis (PrEP) Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Pre-Exposure Prophylaxis (PrEP) Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Pre-Exposure Prophylaxis (PrEP) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Pre-Exposure Prophylaxis (PrEP) Sales by Country (K Units), 2021–2026
 Table 32. Europe Pre-Exposure Prophylaxis (PrEP) Sales by Country (K Units), 2027–2032
 Table 33. Europe Pre-Exposure Prophylaxis (PrEP) Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Pre-Exposure Prophylaxis (PrEP) Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Pre-Exposure Prophylaxis (PrEP) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Pre-Exposure Prophylaxis (PrEP) Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Pre-Exposure Prophylaxis (PrEP) Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Pre-Exposure Prophylaxis (PrEP) Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Pre-Exposure Prophylaxis (PrEP) Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Pre-Exposure Prophylaxis (PrEP) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Pre-Exposure Prophylaxis (PrEP) Sales by Country (K Units), 2021–2026
 Table 42. Latin America Pre-Exposure Prophylaxis (PrEP) Sales by Country (K Units), 2027–2032
 Table 43. Latin America Pre-Exposure Prophylaxis (PrEP) Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Pre-Exposure Prophylaxis (PrEP) Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Pre-Exposure Prophylaxis (PrEP) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Pre-Exposure Prophylaxis (PrEP) Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Pre-Exposure Prophylaxis (PrEP) Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Pre-Exposure Prophylaxis (PrEP) Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Pre-Exposure Prophylaxis (PrEP) Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Pre-Exposure Prophylaxis (PrEP) Sales (K Units) by Type (2021–2026)
 Table 51. Global Pre-Exposure Prophylaxis (PrEP) Sales (K Units) by Type (2027–2032)
 Table 52. Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Type (2021–2026)
 Table 53. Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Type (2027–2032)
 Table 54. Global Pre-Exposure Prophylaxis (PrEP) Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Pre-Exposure Prophylaxis (PrEP) Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Type (2021–2026)
 Table 57. Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Type (2027–2032)
 Table 58. Global Pre-Exposure Prophylaxis (PrEP) Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Pre-Exposure Prophylaxis (PrEP) Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Pre-Exposure Prophylaxis (PrEP) Sales (K Units) by Application (2021–2026)
 Table 61. Global Pre-Exposure Prophylaxis (PrEP) Sales (K Units) by Application (2027–2032)
 Table 62. Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Application (2021–2026)
 Table 63. Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Application (2027–2032)
 Table 64. Global Pre-Exposure Prophylaxis (PrEP) Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Pre-Exposure Prophylaxis (PrEP) Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Application (2021–2026)
 Table 67. Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Application (2027–2032)
 Table 68. Global Pre-Exposure Prophylaxis (PrEP) Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Pre-Exposure Prophylaxis (PrEP) Price (US$/Unit) by Application (2027–2032)
 Table 70. Gilead Sciences Company Information
 Table 71. Gilead Sciences Description and Business Overview
 Table 72. Gilead Sciences Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Gilead Sciences Pre-Exposure Prophylaxis (PrEP) Product
 Table 74. Gilead Sciences Recent Developments/Updates
 Table 75. ViiV Healthcare Company Information
 Table 76. ViiV Healthcare Description and Business Overview
 Table 77. ViiV Healthcare Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. ViiV Healthcare Pre-Exposure Prophylaxis (PrEP) Product
 Table 79. ViiV Healthcare Recent Developments/Updates
 Table 80. Teva Company Information
 Table 81. Teva Description and Business Overview
 Table 82. Teva Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Teva Pre-Exposure Prophylaxis (PrEP) Product
 Table 84. Teva Recent Developments/Updates
 Table 85. Amneal Pharmaceuticals Company Information
 Table 86. Amneal Pharmaceuticals Description and Business Overview
 Table 87. Amneal Pharmaceuticals Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Amneal Pharmaceuticals Pre-Exposure Prophylaxis (PrEP) Product
 Table 89. Amneal Pharmaceuticals Recent Developments/Updates
 Table 90. Aurobindo Pharma Company Information
 Table 91. Aurobindo Pharma Description and Business Overview
 Table 92. Aurobindo Pharma Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Aurobindo Pharma Pre-Exposure Prophylaxis (PrEP) Product
 Table 94. Aurobindo Pharma Recent Developments/Updates
 Table 95. Mylan Company Information
 Table 96. Mylan Description and Business Overview
 Table 97. Mylan Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Mylan Pre-Exposure Prophylaxis (PrEP) Product
 Table 99. Mylan Recent Developments/Updates
 Table 100. Zydus Company Information
 Table 101. Zydus Description and Business Overview
 Table 102. Zydus Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Zydus Pre-Exposure Prophylaxis (PrEP) Product
 Table 104. Zydus Recent Developments/Updates
 Table 105. Qilu Pharmaceutical Company Information
 Table 106. Qilu Pharmaceutical Description and Business Overview
 Table 107. Qilu Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Qilu Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Product
 Table 109. Qilu Pharmaceutical Recent Developments/Updates
 Table 110. Anhui Baker Biopharmaceutical Company Information
 Table 111. Anhui Baker Biopharmaceutical Description and Business Overview
 Table 112. Anhui Baker Biopharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Anhui Baker Biopharmaceutical Pre-Exposure Prophylaxis (PrEP) Product
 Table 114. Anhui Baker Biopharmaceutical Recent Developments/Updates
 Table 115. Chengdu Brilliant Pharmaceutical Company Information
 Table 116. Chengdu Brilliant Pharmaceutical Description and Business Overview
 Table 117. Chengdu Brilliant Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Chengdu Brilliant Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Product
 Table 119. Chengdu Brilliant Pharmaceutical Recent Developments/Updates
 Table 120. North China Pharmaceutical Company Information
 Table 121. North China Pharmaceutical Description and Business Overview
 Table 122. North China Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. North China Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Product
 Table 124. North China Pharmaceutical Recent Developments/Updates
 Table 125. Chia Tai Tianqing Pharmaceutical Company Information
 Table 126. Chia Tai Tianqing Pharmaceutical Description and Business Overview
 Table 127. Chia Tai Tianqing Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Chia Tai Tianqing Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Product
 Table 129. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Pre-Exposure Prophylaxis (PrEP) Distributors List
 Table 133. Pre-Exposure Prophylaxis (PrEP) Customers List
 Table 134. Pre-Exposure Prophylaxis (PrEP) Market Trends
 Table 135. Pre-Exposure Prophylaxis (PrEP) Market Drivers
 Table 136. Pre-Exposure Prophylaxis (PrEP) Market Challenges
 Table 137. Pre-Exposure Prophylaxis (PrEP) Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pre-Exposure Prophylaxis (PrEP)
 Figure 2. Global Pre-Exposure Prophylaxis (PrEP) Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Pre-Exposure Prophylaxis (PrEP) Market Share by Type: 2025 & 2032
 Figure 4. Oral PrEP Product Picture
 Figure 5. Injectable PrEP Product Picture
 Figure 6. Global Pre-Exposure Prophylaxis (PrEP) Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Pre-Exposure Prophylaxis (PrEP) Market Share by Application: 2025 & 2032
 Figure 8. Hospital and Clinic
 Figure 9. Pharmacy
 Figure 10. Other
 Figure 11. Global Pre-Exposure Prophylaxis (PrEP) Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Pre-Exposure Prophylaxis (PrEP) Market Size (US$ Million), 2021–2032
 Figure 13. Global Pre-Exposure Prophylaxis (PrEP) Sales (K Units), 2021–2032
 Figure 14. Global Pre-Exposure Prophylaxis (PrEP) Average Price (US$/Unit), 2021–2032
 Figure 15. Pre-Exposure Prophylaxis (PrEP) Report Years Considered
 Figure 16. Pre-Exposure Prophylaxis (PrEP) Sales Share by Manufacturers in 2025
 Figure 17. Global Pre-Exposure Prophylaxis (PrEP) Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Pre-Exposure Prophylaxis (PrEP) Players: Market Share by Revenue in Pre-Exposure Prophylaxis (PrEP) in 2025
 Figure 19. Pre-Exposure Prophylaxis (PrEP) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Pre-Exposure Prophylaxis (PrEP) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Country (2021–2032)
 Figure 22. North America Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Country (2021–2032)
 Figure 23. United States Pre-Exposure Prophylaxis (PrEP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Pre-Exposure Prophylaxis (PrEP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Country (2021–2032)
 Figure 26. Europe Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Pre-Exposure Prophylaxis (PrEP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Pre-Exposure Prophylaxis (PrEP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Pre-Exposure Prophylaxis (PrEP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Pre-Exposure Prophylaxis (PrEP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Pre-Exposure Prophylaxis (PrEP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Region (2021–2032)
 Figure 34. China Pre-Exposure Prophylaxis (PrEP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Pre-Exposure Prophylaxis (PrEP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Pre-Exposure Prophylaxis (PrEP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Pre-Exposure Prophylaxis (PrEP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Pre-Exposure Prophylaxis (PrEP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Pre-Exposure Prophylaxis (PrEP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Pre-Exposure Prophylaxis (PrEP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Pre-Exposure Prophylaxis (PrEP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Pre-Exposure Prophylaxis (PrEP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Pre-Exposure Prophylaxis (PrEP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Pre-Exposure Prophylaxis (PrEP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Pre-Exposure Prophylaxis (PrEP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Pre-Exposure Prophylaxis (PrEP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Pre-Exposure Prophylaxis (PrEP) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Pre-Exposure Prophylaxis (PrEP) by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Pre-Exposure Prophylaxis (PrEP) by Type (2021–2032)
 Figure 54. Global Pre-Exposure Prophylaxis (PrEP) Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Pre-Exposure Prophylaxis (PrEP) by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Pre-Exposure Prophylaxis (PrEP) by Application (2021–2032)
 Figure 57. Global Pre-Exposure Prophylaxis (PrEP) Price (US$/Unit) by Application (2021–2032)
 Figure 58. Pre-Exposure Prophylaxis (PrEP) Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Drugs for PrEP Market Research Report 2024
Global Parenteral PrEP Market Research Report 2024
Global Long acting PrEP Market Research Report 2024
Global Injectable HIV Medication Market Research Report 2024
Prophylactic HIV Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tenofovir Disoproxil Fumarate Tablets Market Research Report 2024
Global Tenofovir Fumarate Market Research Report 2024
Global Injectable HIV Treatment Market Research Report 2024
Global HIV Prevention Drug Market Research Report 2024
Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Research Report 2024
HIV Antiretroviral Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global HIV Therapy Market Research Report 2025
Global Preoperative Skin Preparation Products Market Research Report 2024
Global Preoperative Skin Preparation Market Research Report 2024
Global Hair Preparation Market Research Report 2024
Pre Exposure Prophylaxis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tenofovir Disoproxil Fumarate API Market Research Report 2025
Global Emtricitabine and Tenofovir Disoproxil Fumarate Tablets Market Research Report 2024
Global Clinical Sample Prep System Market Research Report 2024
Global Prophylaxis Angles And Cups Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions